Study 7 of 143 for search of: "Burns"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns
This study has been terminated.
Sponsored by: Air Liquide Santé International
Information provided by: Air Liquide Santé International
ClinicalTrials.gov Identifier: NCT00643357
  Purpose

The purpose of this study is to assess the efficacy and the safety of Kalinox® 170 bar, over a period of three consecutive care procedures in burned children. It's a international (Spain, France, Tunisia and Belgium) study with 8 investigator centers.


Condition Intervention Phase
Burns
Drug: 50% Oxygen/50% Nitrous oxide premix (KALINOX 170 bar)
Drug: 50%Oxygen/50% Nitrogen premix
Phase III

MedlinePlus related topics: Burns
Drug Information available for: Nitrous oxide
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Study of the Efficacy and Safety of KALINOX® 170 Bar for the Performance of Care Procedures in Children With Burns

Further study details as provided by Air Liquide Santé International:

Primary Outcome Measures:
  • The intensity of the pain was assessed using the "Faces Pain Scale Revised" [ Time Frame: Faces Pain Scale Revised ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: March 2008
Estimated Study Completion Date: June 2008
Estimated Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
50% Oxygen/50% Nitrous oxide premix (Kalinox® 170 bar)
Drug: 50% Oxygen/50% Nitrous oxide premix (KALINOX 170 bar)
gaz flow between 4 to 15 L/min inhalation between 15 to 60 minutes
B: Placebo Comparator
50%Oxygen/50% Nitrogen premix
Drug: 50%Oxygen/50% Nitrogen premix
inhalation between 15 to 60 minutes gaz flow between 4 to 15 l/min

Detailed Description:

Pain due to burns is one of the most intense and persistent types of pain. This pain consists of a permanent background pain, overlaid by episodes of temporary exacerbations triggered by treatment procedures or burn-care procedures.

Care procedures, such as changing the dressings or cleaning the wounds, make it necessary to handle the painful areas, and this causes transient intense pain.

Analgesia with a 50/50 mix of nitrous oxide and oxygen is a simple and effective technique, which induces a state of light sedation during which verbal contact is not lost, which is rapidly reversible and is devoid of any major side effects. This gas is used in paediatrics for carrying out painful procedures of a short duration, such as lumbar puncture and minor surgery.

The nitrous oxide/oxygen mix has also been used to treat the pain induced by care procedures in children with burns for more than 30 years.

The objective of our study is to obtain qualitative and quantitative data about the efficacy of Kalinox® 170 bar in care procedures in children with burns.

  Eligibility

Ages Eligible for Study:   4 Years to 15 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care

    • potentially mildly to moderately painful
    • lasting for at least 15 minutes and for less than 30 minutes
    • eligible to receive short-term prophylactic analgesic treatment
    • for whom the consent form has been signed (parent and child)

Exclusion criteria:

  • Child treated under general anaesthesia
  • Child physically or mentally incapable of responding to an assessment of his/her pain on a visual scale.
  • Child suffering from moderate to severe pain when beginning the care procedure (FPSr > 4)
  • Exclusion criteria linked to the product
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Air Liquide Santé International ( peter Onody / Pharmacist and director of medico-marketing department )
Study ID Numbers: 2006-002698-38
Study First Received: March 19, 2008
Last Updated: January 9, 2009
ClinicalTrials.gov Identifier: NCT00643357  
Health Authority: France: Afssaps - French Health Products Safety Agency;   Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment;   Spain: Spanish Agency of Medicines

Keywords provided by Air Liquide Santé International:
children with burns
Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care

Study placed in the following topic categories:
Burns
Nitrous Oxide
Wounds and Injuries
Disorders of Environmental Origin

Additional relevant MeSH terms:
Anesthetics, Inhalation
Anesthetics, General
Sensory System Agents
Analgesics, Non-Narcotic
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Anesthetics
Peripheral Nervous System Agents
Analgesics
Central Nervous System Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009